Posts for Ticker ‘BCRX’

Top Day Trader Alerts (BCRX, DELL, DRYS, NVAX, WCRX)

These are this morning’s top day trader alerts and active trader alerts early this Friday morning.  We have links through to each stock at VSInvestor.com with more data and analysis on each:

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) down almost 6% on its secondary offering.

Dell Inc. (NASDAQ: DELL) is down 8% on earnings, but we came up with the technical levels to watch in moving averages and prior pivot points.

DryShips Inc. (NASDAQ: DRYS) is down almost 4% after it increased the size of its convertible note offering.

Novavax, Inc. (NASDAQ: NVAX) is trading down 10% on a secondary offering on deck.

Warner Chilcott plc (NASDAQ: WCRX) is down only 2% after insiders and private equity holders are selling shares in a secondary offering.

You can join our open email distribution list to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG
NOVEMBER 20, 2009

Posted on: November 20, 2009 – 8:44 am in Pre-Market Activity, Trading Alert, , , , ,

Top Day Trader Alerts (FITB, STI, CIT, AMZN, BCRX, LM)

This morning you are getting the broader summaries without links to VSInvestor.com because of an issue at the hosting and publishing side that has caused a temporary outage.  Here are brief morning movers:

Fifth Third Bancorp (NASDAQ: FITB) and SunTrust Banks, Inc. (NYSE: STI) are both getting hit this morning on an analyst downgrade by Dick Bove.  Rochdale Securities has downgraded the bank to Sell from an already cautious Neutral rating.  At 8:20 AM EST we have seen STI shares down over 2.5% at $20.45 on about 10,000 shares and FITB is down over 4% at $9.92 on 65,000 shares. STI trades about 9.7 million shares per day and and FITB trades about 22 million shares per day.

CIT Group, Inc. (NYSE: CIT) is trading up this morning on news that could ultimately be bad for shareholders.  CIT has amended its debt offering terms under a packaged bankruptcy reorganization.  CIT is up 3.5% at $1.18 on over 400,000 shares of stock at 8:26 AM EST.  As a reminder, CIT was under fire on Friday by a Carl Icahn open letter to bondholders calling that the value of the bonds could be Par (100 cents on the dollar).  CIT trades close to 90 million shares per day and where this one closes today is anyone’s guess as of now.

Amazon.com Inc. (NASDAQ: AMZN) rose almost $25.00 on Friday on over 58 million shares when you include the pre-open and after-hours trading volume.   Average volume here is about 7 million shares.  And this morning at 8:30 AM EST we have shares up another 1.8% at $120.60 on right at 300,000 shares.  This will mark new 52-week highs  as the high on Friday was $119.65.  Bezos always wanted to build a rocket ship, and his stock is acting like one.

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is surging on H1N1 news this morning.  The company’s intravenous experimental drug called peramivir received an “emergency use authorization” by the FDA as a swine flu treatment  from the Food and Drug Administration as a swine flu treatment in hospitals for thoise with or suspected of having swine flu.

Legg Mason Inc. (NYSE: LM) is indicated higher.  Billionaire investor Nelson Peltz will join the asset management firm’s board after his investment firm has now taken a 4.3% stake in the company.  This investment is via Peltz’s Trian investment group.  3.6% at $33.05, but volume is still very thin as this is a listed stock under an NYSE specialist.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

Jon C. Ogg
October 26, 2009

Posted on: October 26, 2009 – 9:10 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , ,

Today’s Best Market Rumors (10/2/2009) (AAPL)(GE)(BAC)(GOOG)(TWX)

magazinUpdates throughout the day.

Update: Jeff Bewkes, CEO of Time-Warner (TWX) who says “Time, Inc. is not for sale.” (Atlantic First Draft of American History Conference)

Update:   John Paulson and Angelo Gordon may be buying debt in troubled phone company FairPoint (FRP) (NYPost)

Update:   BioCryst Pharm (BCRX) is spiking higher on takeover rumors (Briefing.com)

Comcast (CMCSA) is not going to buy GE’s (GE) NBC Universal unit or any part of it. (various)

Comcast is close to a joint venture to own NBCU in which the cable firm would own 51% (various)

Chrysler may fold within a year  (24/7 Wall St.)

GE may take NBCU public. (Reuters)

Pay czar Kenneth Feinberg may block Ken Lewis’s $125 million pay package at Bank of America (BAC). (Reuters)

Local.com (LOCM) may or may not be a buyout target for Microsoft (MSFT). The press release making an announcement of the deal is a fake. (Barron’s)

“Bank of England governor Mervyn King may have told economists this week, that the Bank had no immediate plans to change the rate paid to commercial banks on sums deposited overnight, but it appears not everyone believes him.” (FTAlphaville)

Apple (AAPL) plans to replace the decades-old PC “mouse” with touch technology in upcoming Macs. (AppleInsider)

Google (GOOG) has taken access to the homepage of file-sharing service Pirate Bay out of its search results. (The Register)

Apple’s iPhone market share could more than double if its exclusive deal with AT&T (T) ends (SAI).

Brian T. Moynihan, head of Bank of America’s (BAC) consumer unit, may be the top candidateto be the new CEO. (NYTimes)

Douglas A. McIntyre

Posted on: October 2, 2009 – 9:19 am in Rumors, , , , , , , , , , ,

Top Day Trader Alerts (BBY, BCRX, C, DNDN, ING, LXRX, YHOO)

These are this morning’s top pre-market day trader alert stocks.  We have more color and more detail on price and volume analysis linked through to each at VSInvestor.com:

Best Buy Co. (NYSE: BBY) is holding up better than many might guess considering how much it has run up. This is after light earnings.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is fairly close to 52-week highs after signing three partnerships for Peramivir for influenza outside the U.S.

Citigroup Inc. (NYSE: C) is down but only marginally on reports of a ‘possible’ stake sale by The U.S. Government.

Dendreon Corp. (NASDAQ: (DNDN) is giving back a portion of yesterday’s gains on merger rumors.

ING Group (NYSE: ING) will be an active ADR today after the EU may block a settlement.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is surging as a top bio-winner after moving to Phase 2 clinical trial of LX4211 in patients with type 2 diabetes.

Yahoo! Inc. (NASDAQ: YHOO) is soaring to highs not seen since July on yet another upgrade.

You can join our open email distribution list which goes out several times per week for top day trader alerts, top analyst upgrades and downgrades, IPO’s, key secondary offerings, guru investor data on Buffett and others, mergers, and more.

JON C. OGG
September 15, 2009

Posted on: September 15, 2009 – 8:57 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , , ,

Top Day Trader Alerts (ARAY, COCO, GME, HGSI, NVAX, BCRX, SIRI)

These are this Tuesday’s top day trader and active trader alerts with more detailed price and volume data and analysis provided by links to each story at VSInvestor.com:

Accuray Incorporated (NASDAQ: ARAY) is down but not as active on the heels of active trading last night.  We saw a drop of 10% still being in the stock….

Corinthian Colleges, Inc. (NASDAQ: COCO) did beat earnings and raise guidance, sending shares up 12% and still under the 52-week highs.  Watch APOL and CECO on the news….

GameStop Corp. (NYSE: GME) is indicated marginally lower after losing its CFO.

Human Genome Sciences, Inc. (NASDAQ: HGSI) was up the most of the active biotechs up over 7% on yesterday’s deal hopes and today’s swine flu hopes.

Novavax Inc. (NASDAQ: NVAX) and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) are both actively traded and higher this morning because of the swine flu boost.

SIRIUS XM Radio Inc. (NASDAQ: SIRI) is looking a little tired, but this would be a 6th day gain if it can stay strong again.

-The 24/7 Wall Street Team

Posted on: August 25, 2009 – 9:13 am in Pre-Market Activity, Trading Alert, , , , , , ,

Europe Steps Up Timetable On Swine Flu Vaccines (VICL, NVAX, BCRX)

earthShares of vaccine makers including Vical Inc. ((Nasdaq: VICL), Novavax Inc. (Nasdaq: NVAX) and BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) all are up strongly Monday after Europe’s version of the FDA decided to fast-track swine flu vaccine testing, making producers of the yet-to-be-approved inoculations potentially closer to bringing their products to market. Read More »

Posted on: July 27, 2009 – 10:53 am in Biotech, Drug companies, Pharmaceuticals, , ,

Top Day Trader Alerts (CIT, C, BAC, YHOO, BCRX)

These are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis at VSInvestor.com:

CIT Group Inc. (NYSE: CIT) shares rising sharply on volume in the premarket, on speculation that the troubled lender company may sell a unit or reach a financing deal.  If you want to avoid the common stock, you can easily trade higher up in the capital structure as we noted yesterday.

Citigroup Inc. (NYSE: C) shares are rising following its earnings report. The company’s Tier 1 capital ratio was about 12.7%, versus 8.7% in the second quarter of 2008 and 11.9% in the first quarter of 2009.

Bank of America (NYSE: BAC) shares are falling on volume after the company said credit losses were higher than in the prior quarter, reserves rose, and its card services business posted a net loss.

Yahoo Inc. (Nasdaq: YHOO) shares are rising following Google’s earnings and on hopes of a Microsoft deal.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is trading sharply higher on strong pre-market volume on seasonal flu study results.

-The 24/7 Wall St. Team

Posted on: July 17, 2009 – 7:45 am in Pre-Market Activity, Trading Alert, , , , ,

Winning Stocks on a Down Week (ADY, BCRX, DDRX, DGI, FAZ, LORL, RHT, WX)

This was a week of profit taking and a probable realization that a move of 30% and more from the lows in March was probably a bit much in the face of only consistent “less-bad” economic data.  But as every optimist says, “There is always a bull market somewhere.”  We saw a drop of  about -3.6% to 8,268.64, while the S&P 500 Index slid by -4.% to 882.88.  The NASDAQ was the ‘better’ of the losers with a drop of -3.4% to 1,680.14.  But there are many standout stocks, and some of the key big movers and winners this week were American Dairy Inc. (NYSE: ADY), Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX), Diedrich Coffee Inc. (NASDAQ: DDRX), DigitalGlobe, Inc. (NYSE: DGI), Direxion Daily Financial Bear 3X Shares (NYSE: FAZ), Loral Space & Communications, Inc. (NASDAQ: LORL), Red Hat Inc. (NYSE: RHT) and WuXi PharmaTech Inc. (NYSE: WX).

Believe it or not, some of these are up exponentially off of the lows.  One is up 30-fold from the end of March, and amazingly the best winners were not in tech or biotech.  We have provided a weekly synopsis and the reason for their from the lows.
Read More »

Posted on: May 16, 2009 – 8:10 am in HI/LOW, The Week, Trading Alert, Turnarounds, , , , , , , ,

Speculative Swine Flu Stocks Make Last Stand (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)

It looks like everyone has figured out that swine flu was more of a media pandemic rather than a disease or viral pandemic.  Had this been November as flu season was starting, that might have been a bigger deal.  We have seen substantial pullbacks after the massive gains seen in the speculative swine flu stocks.  Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.
Read More »

Posted on: May 5, 2009 – 3:12 pm in Biotech, Trading Alert, , , , , , ,

Speculative Swine Flu Stocks Giving It Back (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)

burning-money-pic32This week there have been many crazy stock gains among the speculative biotech sector, and these were tied directly to the ’speculative stocks’ that could have any ties in reality, fiction, and even imagination to a cure or hope in the fight against Swine Flu or any other sort of flu for that matter.

As you will see below, Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.
Read More »

Posted on: April 29, 2009 – 10:23 am in Biotech, Trading Alert, , , , , , ,

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

burning-money-pic27Monday is looking like a SWINE FLU speculative flu stock stock bonanza, and we want to caution about some of the lessons of scares in the past of SARS, bird flu, Mad Cow, and even hoof & mouth as similar references.  The two approved drug treatments, not vaccines, which are being released are Tamiflu made by Roche (OTC: RHHBY) and Relenza made by GlaxoSmithkline (NYSE: GSK).  Gilead Sciences, Inc. (GILD) gets royalties from Roche for Tamiflu, and its shares are indicated north of $48.00 after a $45.80 close on Friday.  There are also waves of tier-two and tier-three stocks which could move on this news, but be advised that we have seen these pops in the past from SARS and Bird Flu which were followed ultimately by lower share prices and many of the speculative players disappeared.

Of the tier-two stocks, you have BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) and Novavax, Inc. (NASDAQ: NVAX).  Of the tier-three stocks you have Generex Biotechnology Corp. (NASDAQ: GNBT), Vical Inc. (NASDAQ: VICL), AVI Biopharma, Inc. (NASDAQ: AVII), and Crucell NV (NASDAQ: CRXL).  More descriptive data has been provided for each move.   On another scale, Smithfield Foods Inc. (NYSE: SFD), the iShares MSCI Mexico Investable Market Index (NYSE: EWW), and The Mexico Fund, Inc. (NYSE: MXF) have exposure here as well.
Read More »

Posted on: April 27, 2009 – 6:40 am in Biotech, Drug companies, Food, Medical, Pharmaceuticals, Regulation, Research, Trading Alert, , , , , , , , ,

BioCryst Botched Flu Results (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced preliminary findings from a Phase II study with intramuscular injection of Peramivir, the Company’s product candidate for the treatment of seasonal and life-threatening influenza.

It states that 344 patients who had a positive rapid antigen test indicating acute influenza illness were randomized to receive intramuscular injections of either placebo or one of two dose levels of peramivir (150mg and 300mg) as a single dose administered within 48 hours of symptom onset. The primary endpoint of the study was the time to alleviation of symptoms in the patients with confirmed influenza infection (n=313).

Here is the problem……..While the results indicate that in the evaluable population of 313 subjects, a single dose of peramivir demonstrated a treatment improvement over placebo, the improvement was not statistically significant. With regard to the primary endpoint of median time to alleviation of symptoms, the improvement over placebo was 22.9 hours with the 150mg dose (p=0.284) and 21.1 hours with the 300mg dose (p=0.152). Based on a preliminary review, the Company believes that due to the introduction of a shorter injection needle in the Phase II trial compared to the Phase I trial, only one-third of subjects received an adequate intramuscular injection.

The company is moving ahead and it sounds like the company is blaming too many patients receiving shots with too short of a needle.  You’ll have to decide on your own if they are telling the truth or not.

The company just completed a private placement back on August 9 of $65.3 million, so this is going to be a likely burn for many of the investors.  This appears to not be its only oar in the water.  Fodosine is in studies for T-Cell Leukemia, CTCL, Chronic Lymphocytic Leukemia, and B-ALL.  It also is studying BCX-4208 for autoimmune disease and transplantation.

In after-hours trading activity, shares are down nearly 40% at $7.17.  On August 9, back when it completed its private placement, shares closed that day at $9.59 and shares had run up to over $12.00 recently before closing at $11.78 today.  Its 52-week trading range is $6.57 to $13.38.

Jon C. Ogg
September 19, 2007

Posted on: September 19, 2007 – 3:52 pm in Biotech, , , , ,

Massive List of 52-Week Lows (June 20, 2007)

Stock Tickers: AVR, BCRX, CACH, CHCI, COLY, CTIC, FSII, HOV, HR, INFS, LEG, MTH, PEIX, RSYS, SCSS, SEPR, SNY, STAA, USBE, UTSI, VSE, YSI

Once again, many many more losers…..This list is larger than most of recent note.  There is just about any given day where there are fresh 52-week lows:

Aventine Renewable (AVR)…-3.9% to $14.09; $14.60 prior low.  Watch the renewable energy names as they are plentiful on 52-week lows.

BioCryst Pharma (BCRX)…-3.3% at $6.92; prior 52-week low $7.13; follow-on weakness from Peramivir Monday.

Cache (CACH)…-2.7% to $13.92; not lowest intraday but low close.

Comstock Homebuilders (CHCI)…-4.4% to $2.83; another stinking homebuilder.

Coley Pharma (COLY)….-59% to $3.46; $8.00 prior lows; intra-day implosion as Pfizer ditches its cancer drug.

Cell Therapeutics (CTIC)…-9.4% to $3.09; prior 52-week low was $3.38.

FSI International (FSII)….-13% to $3.43; $3.91 was prior low; weak guidance; hedge fund pressures CEo.

Hovnanian Enterprises (HOV)…-3% to $19.08; prior 52-week low $19.53; another stinking homebuilder.

Healthcare Realty (HR) -2.2% to $28.34; prior 52-week low was $28.57; this one goes lower and lower each week it feels like.

InFocus (INFS) -4% to $2.33; follow-on weakness after CFO quit; stock imploding….

Leggett & Platt (LEG)…-0.7% to $21.92; not tru 52-week low but low close; continued weakness after estimates cut from housing.

Meritage Homes (MTH)..-1.5% to $28.75; another stinking homebuilder.

Pacific Ethanol (PEIX)…-2.35 to $12.35; lowest close of late; and we thought ethanol was king…..

Radisys (RSYS)…-3.8% to $12.80; not true low but low close and hit intraday lows; no news today.

Select Comfort (SCSS)…-2.1% to $16.03; prior low $16.09; weak housing must mean weak bed sales; maybe hamocs are the new rage?

Sepracor (SEPR)…-2.5% to $43.67; prior 52-week low $43.84; insiders exercising stock options this week; P/E ratio drifting lower and lower; now down 33% from highs.

Sanofi-Aventis (SNY)…-1.8% to $40.84; prior low $41.09; drug woes continue; worries they’ll dilute to buy Bristol-Myers.

Staar Surgical (STAA)…-2.85% to $4.09; $4.14 prior 52-week lows; no news, but not a ’staar’ after all.

US Bioenergy (USBE)…-2.6% to $10.67; $10.78 prior low; busted IPO looks like worse getting even worse.

UTSarcom (UTSI)…-3.8% to $5.28; $5.43 was prior 52-week low; down more than 50% in last year; the beatings will continue until leadership improves AND until they actually report and open the books.

VeraSun (VSE)…-4.7% to $13.08; $13.69 was prior 52-week low; ethanol slide continues.

u_Store-It Trust (YSI)…-2.9% to $16.97; $17.05 was prior intra-day low; no news, but they obviously aren’t storing enough.

Jon C. Ogg
June 20, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in any of the companies he covers.

Posted on: June 20, 2007 – 3:38 pm in HI/LOW, , , , , , , , , , , , , , , , , , , , , ,

52-Week Low Club (June 8, 2007)

Stock Tickers: AZN, BCRX, EHTH, CTIC, HW, NRMX, SBUX, WFMI, DUK

It’s no secret we had the makings of a crummy week, but the market managed to turn itself back around after a fairly week open.  Regardles of a bull market or any market, there are still stocks hitting 52-week lows:

AstraZeneca (AZN) ADR’s put in lows, two days after the CFO left to join Goldman Sachs.

BioCryst (BCRX) stays weak, apparently the near-term bounce turned back into a pounce.

Cell Therapeutics (CTIC) managed to keep its post-ASCO slide going.

eHealth, Inc (EHTH) put in the lowest close since its October IPO.

Headwaters (HW) just keeps slipping and looks uglier daily, and has been oin a crash course for about 6 weeks..

Neurochem (NRMX) closed down another 10% after the poor drug outlook yesterday.

Starbucks (SBUX) and Whole Foods (WFMI) were in the 52-week low gutter club earlier but got bailed out by the market offer. Duke Energy (DUK) also rode most of the day on new adjusted lows before an end of day recovery, although these might not be ultimate 52-week lows on an adjusted basis.

Jon C. Ogg
June 8, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 8, 2007 – 3:29 pm in HI/LOW, , , , , , , , ,